BMT data from Klein and Moeschberger

Description

A data frame of 137 rows (patients) and 22 columns. The included variables are

group

Disease group; 1 = ALL, 2 = AML Low Risk, 3 = AML High Risk

t1

Time in days to death or last follow-up

t2

Disease-free survival time in days (time to relapse, death or last follow-up)

d1

Death indicator; 1 = dead, 0 = alive

d2

Relapse indicator; 1 = relapsed, 0 = disease-free

d3

Disease-free survival indicator; 1 = dead or relapsed, 0 = alive and disease-free)

ta

Time in days to Acute Graft-versus-Host Disease (AGVHD)

da

Acute GVHD indicator; 1 = Acute GVHD, 0 = No Acute GVHD

tc

Time (days) to Chronic Graft-vrsus-Host Disease (CGVHD)

dc

Chronic GVHD indicator; 1 = Chronic GVHD, 0 = No Chronic GVHD

tp

Time (days) to platelet recovery

dp

Platelet recovery indicator; 1 = platelets returned to normal, 0 = platelets never returned to normal

z1

Patient age in years

z2

Donor age in years

z3

Patient sex; 1 = male, 0 = female

z4

Donor sex; 1 = male, 0 = female

z5

Patient CMV status; 1 = CMV positive, 0 = CMV negative

z6

Donor CMV status; 1 = CMV positive, 0 = CMV negative

z7

Waiting time to transplant in days

z8

FAB; 1 = FAB grade 4 or 5 and AML, 0 = Otherwise

z9

Hospital; 1 = The Ohio State University, 2 = Alferd , 3 = St. Vincent, 4 = Hahnemann

z10

MTX used as a Graft-versus-Host prophylactic; 1 = yes, 0 = no

Format

A data frame, see data.frame.

References

Klein and Moeschberger (1997). Survival Analysis Techniques for Censored and Truncated Data, Springer, New York.